pathology of breast disease Flashcards

1
Q

normal structure of the breast - lobes and lobules

A

each breast has 8-10 lobes (arranged like daisy petals)
inside each lobe are smaller structures called lobules
at the end of each lobule are bulbs that can produce milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

changes to breasts in puberty - ducts

A

before puberty - breasts in both sexes, ducts

variable degrees of branching, lack lobules
15-25 lactiferous ducts
start at the nipple and branch until terminal ductal lobular unit
hormonally responsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

lymph ducts in the breast

A

drain fluid carrying WBCs fromt he breast tissue into LNs in the axilla and behind the sternum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lymph nodes in the breasts

A

filter harmful bacteria

play a key role in fighting off infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

give 5 examples of benign breast conditions

A
fibrocystic change 
fibroadenoma 
intraduct papilloma - lactiferous ducts, nipple discharge
fat necrosis - traumatic
duct ectasia - nipple discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

examples of fibrocystic change

A
fibrosis 
adenosis 
cysts 
apocrine metaplasia 
ductal epithelial hyperplasia (usal type, atypical)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a fibroadenoma

A

well circumscribed, freely mobile, non-painful mass

proliferation of epithelial and stromal elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how common are fibroadenomas

A

most common breast tumour in adolescent and young adult women

peak age - 3rd decade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can happen to fibroadenomas if untreated

A

may regress with age if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

growth pattern in fibroadenomas

A

ducts distorted and elongated –> slit like structures, intracanalicular pattern, ducts not compressed –> pericanalicular growth pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

intraductal papilloma

  • who
  • key symptom
  • features
A

usually middle aged women
nipple discharge
can show epithelial hyperplasia which may be atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fat necrosis - what can it result in

A

can stimulate carcinoma - clinically and mammographically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what causes fat necrosis

A

hx of antecedent trauma, prior to surgical intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

histological features of fat necrosis

mammography features

A

histiocytes with foamy cytoplasm
lipid-filled cysts

fibrosis, calcifications, egg shell on mammography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Phyllodes tumour

A

fleshy tumour, leaf like pattern and cysts on cut surface

circumscribed, connective tissue and epithelial elements

1-15cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how common are Phyllodes tumour

A

<1% of breast tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what type of tumours are Phyllodes tumour

what about the mets

A

benign, borderline, malignant

mets are hematogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

breast cancer incidence

A

2.3mln new cases 2020
incidence increasing in most countries
685 000 deaths
commonest cancer in UK (15%)

55200 new cases p/a UK, 4700 scotland

390 male breast cancer p/a UK, 31 scotland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

risk factors for breast cancer

A
gender
age 
menstrual hx
age at 1st pregnancy
radiation
FHx
personal hx
hormonal treatment
genetics
other: obesity, lack of physical activity, alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

causes of hereditary susceptibility to breast cancer

gene, contribution to hereditary breast cancer

A
BRCA1 20-40%
BRCA2 10-30%
TP53 <1%
PTEN <1%
other 30-70%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

histological classification of breast cancer

A

non-invasive

invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

non-invasive breast cancers

A

ductal carcinoma in situ (DCIS)

lobular carcinoma in situ (LCIS/LISN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

invasive breast cancers

A
invasive no special type (ductal) carcinoma, NST (~75%)
special types (rest) incl. invasive lobular carcinoma and variants (5-15%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

features of in situ carcinoma

A
pre-invasive - no palpable tumour formed
not detected clinically - only x-ray in DCIS screening 
multi centricity and bilaterality (LCIS)
no mets - basement membrane 
risk of invasion depending on grade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

in situ cancer - risk of progression

A

low grade DCIS - 30% in 15yrs
high grade DCIS - 50% in 8yrs
LCIS - 19% in 25yrs and bilaterality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

histological classification - pure special types

A
>90% of tumour showing characteristic features of a specific type: 
tubular carcinoma 
cribiform carcinoma 
mucinous carcinoma 
carcinoma w/ medullary features
metaplastic carcinoma 
others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

histological classification - NST and mixed carcinoma

A

NST carcinoma - up to 75% of cases
invasive tumour shows none of <50% of special type features

mixed carcinoma:
heterogenous morphology
50-<90% special type morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is shown

A

normal breast tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is shown

A

normal breast tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what is shown

A

involution - progressive decrease in the size of an organ usually associated with a decline in function

31
Q

what cells can be seen here

A

epithelial and myoepithelial cells

32
Q

what type of change can be seen here

A

fibrocystic change

33
Q

what tumour type is shown here

A

fibroadenoma

34
Q

what tumour type is shown here

A

intraductal papilloma

35
Q

what change is shown here

A

fat necrosis

36
Q

what tumour type is shown here

A

Phyllodes tumour

37
Q

what carcinoma is shown here

A

LCIS

38
Q

what carcinoma type is shown here

A

NST carcinoma

39
Q

what grade would this carcinoma be

A

3

40
Q

what carcinoma is shown here

A

ILC

41
Q

what carcinoma is shown here

A

tubular carcinoma

42
Q

what carcinoma type is shown here

A

tubular carcinoma

43
Q

what carcinoma type is shown here

A

medullary

44
Q

what carcinoma type is shown here

A

mucinous

45
Q

what carcinoma type is shown here

A

micropapillary

46
Q

diagnostic procedures for breast cancer

A
clinical examination
radiology - mammogram, US, MRI
FNA cytology
needle core biopsy 
diagnostic excision
47
Q

what is included in the histology report

A
invasive vs non-invsaive 
histological type - ductal (85%) vs lobular
grade - estimate of aggressiveness under microscope
size
margins
LNs
estrogen/progesterone receptor (2/3 +ve)
HER-2/neu
48
Q

how can breast cancer spread

A

local - skin, pectoral muscles
lymphatic - axillary and internal mammary nodes
blood - bone, lungs, liver, brain

49
Q

spread of breast cancer - what is shown here

A

LVSI

Lymphovascular space invasion

50
Q

spread of breast cancer - what is shown here

A

LN mets

51
Q

determining prognosis of breast cancer

A
patient related and tumour related
node status - best prognostic indicator 
tumour size (<2cm) 
type 
grade (1,2,3)
age 
lymphovascular space invasion 
oestrogen receptors (ER), progesterone receptors (PR)
HER-2
proliferative rate of tumour 
gene expression profiling 
NPI - tumour size, grade, nodal status
52
Q

what is the overall 5YS for breast cancer

A

64%

53
Q

molecular markers for breast cancer and clinical applications

A

ER/PR - strong predictors of response to hormonal therapies

ER/PR-ve tumours do NOT respond
HER-2: ~20-30% +ve, predicts response to trastuzumab (herceptin)

54
Q

what is shown here

A

oestrogen receptors

55
Q

what is shown here

A

HER-2

56
Q

molecular classification of cancers

A

gene expression technology
5 subtypes
biologically diverse disease
predictive gene signatures/potential to improve therapy
complement current clinicopathological features

57
Q

molecular classification - what are the 5 subtypes

A
ER+ luminal A
lumina B 
basal 
HER 2+ 
normal breast like
58
Q

luminal A features and prevalence

A

ER +ve
HER 2 -ve
low Ki67

55%

59
Q

luminal B features and prevalence

A

ER+ve
HER2 +ve (or -ve w/ high Ki67)

15%

60
Q

triple -ve/basal like features and prevalence

A

ER -ve
PR -ve
HER2 -ve

10-15%

61
Q

HER2 type features and prevalence

A

ER -ve
PR -ve
HER2 +ve

15-20%

62
Q

what is true recurrence

A

carcinoma survives initial treatment and recurs

63
Q

what is a new 1y

A

a 2nd cancer which is biologically different from 1st cancer

64
Q

what % of breast cancer patients will develop a 2nd cancer

A

~10% of pts undergoing breast conservation for breast cancer will develop a 2nd cancer within 10yrs

<10yrs - majority are true recurrences
10 yrs - 50/50
>10yrs - majority are new 1ys

65
Q

when is the incidence of recurrence more

A

more in triple -ve breast cancer compared to ER or HER2 +ve cancers

66
Q

prognosis with true recurrence

A

poorer prognosis that new 1ys (depending on stage of new cancer)

pathological features are inaccurate in 40%

67
Q

what is Paget’s disease of the nipple

A

result of intraepithelial spread of intraductal carcinoma

68
Q

histological features of Paget’s disease of the nipple

A

large pale staining cells within the epidermis of the nipple

69
Q

clinical features of Paget’s disease of the nipple

A

limited to the nipple or can extend to the areola
pain/itching, scaling, redness - mistaken for eczema

ulceration, crusting, serous/bloody discharge

70
Q

what is shown here

A

Paget’s disease

71
Q

gynaecomastia

A

most common clinical and pathologic abnormality of the male breast

increase in subareolar tissue

in 30-40% of adult males, both breasts are affected in many cases

72
Q

what is gynaecomastia associated with

A
hyperthyroidism 
liver cirrhosis 
chronic renal failure 
chronic pulmonary disease
hypogonadism 
use of hormones - oestrogens, androgens 
drugs - digitalis, cimetidine, spironolactone, marijuana, tricyclic antidepressants
73
Q

carcinoma of the male breast prevalence

A

uncommon

<1% of all breast cancers